NFKB1 and Miyoshi myopathy: KDM6B expression in MM is induced by bone marrow stromal cells; conversely, this response is abrogated by IKKβ inhibitor MLN120B, indicating that KDM6B is activated via NF-κB signaling, a crucial survival pathway in MM cells82.